These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14510351)

  • 1. Molecular recognition in P2 nucleotide receptors.
    Jacobson KA
    Nucleic Acids Res Suppl; 2003; (3):3-4. PubMed ID: 14510351
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensory transduction of the ischemic myocardium.
    Ardell JL
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1753-4. PubMed ID: 20952672
    [No Abstract]   [Full Text] [Related]  

  • 3. The synthesis and initial characterization of an immobilized purinergic receptor (P2Y1) liquid chromatography stationary phase for online screening.
    Moaddel R; Calleri E; Massolini G; Frazier CR; Wainer IW
    Anal Biochem; 2007 May; 364(2):216-8. PubMed ID: 17391632
    [No Abstract]   [Full Text] [Related]  

  • 4. Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites.
    Moro S; Guo D; Camaioni E; Boyer JL; Harden TK; Jacobson KA
    J Med Chem; 1998 Apr; 41(9):1456-66. PubMed ID: 9554879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomenclature and classification of purinoceptors.
    Fredholm BB; Abbracchio MP; Burnstock G; Daly JW; Harden TK; Jacobson KA; Leff P; Williams M
    Pharmacol Rev; 1994 Jun; 46(2):143-56. PubMed ID: 7938164
    [No Abstract]   [Full Text] [Related]  

  • 6. Ribose modified nucleosides and nucleotides as ligands for purine receptors.
    Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2Y receptor-mediated inhibition of voltage-activated Ca(2+) currents in PC12 cells.
    Vartian N; Boehm S
    Eur J Neurosci; 2001 Mar; 13(5):899-908. PubMed ID: 11264662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet surface physiology and its importance in pharmacotherapy design and development: the adenosine diphosphate receptor antagonists.
    Becker RC
    J Thromb Thrombolysis; 2000 Aug; 10(1):35-53. PubMed ID: 10947913
    [No Abstract]   [Full Text] [Related]  

  • 9. Release and interconversion of P2 receptor agonists by human osteoblast-like cells.
    Buckley KA; Golding SL; Rice JM; Dillon JP; Gallagher JA
    FASEB J; 2003 Aug; 17(11):1401-10. PubMed ID: 12890693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems biology meets platelet biology.
    Berndt MC; Andrews RK
    Blood; 2008 Nov; 112(10):3920-1. PubMed ID: 18988872
    [No Abstract]   [Full Text] [Related]  

  • 11. Purinergic P2X4 receptors are involved in the modulation of giant depolarizing potentials in the hippocampus of newborn rat.
    Safiulina VF; Bikbulatova LS; Mel'nik AI; Rebrov IG; Bazian AS
    Dokl Biol Sci; 2005; 403():250-2. PubMed ID: 16358563
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.
    Horiuchi T; Dietrich HH; Hongo K; Dacey RG
    Stroke; 2003 Jun; 34(6):1473-8. PubMed ID: 12730558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2 receptors in health and disease.
    Weisman GA; Yu N; Liao Z; Gonzaléz F; Erb L; Seye CI
    Biotechnol Genet Eng Rev; 2006; 22():171-95. PubMed ID: 18476331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine triphosphate is full antagonist at human P2Y(1) purinoceptors.
    Sak K; Järv J
    Neurosci Lett; 2000 Apr; 284(3):179-81. PubMed ID: 10773428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of P2-receptors in human fallopian tubes.
    Ziganshin AU; Vafina ZR; Fatkullin IF
    Bull Exp Biol Med; 2004 Mar; 137(3):242-5. PubMed ID: 15232629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2-purinergic receptors: subtype-associated signaling responses and structure.
    Harden TK; Boyer JL; Nicholas RA
    Annu Rev Pharmacol Toxicol; 1995; 35():541-79. PubMed ID: 7598506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2-pyrimidinergic receptors and their ligands.
    Müller CE
    Curr Pharm Des; 2002; 8(26):2353-69. PubMed ID: 12369950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purinergic Receptors in Thrombosis and Inflammation.
    Hechler B; Gachet C
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2307-15. PubMed ID: 26359511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An elusive receptor is finally caught: P2Y(12'), an important drug target in platelets.
    Barnard EA; Simon J
    Trends Pharmacol Sci; 2001 Aug; 22(8):388-91. PubMed ID: 11478981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chimeric rat brain P2Y1 receptor tagged with green-fluorescent protein: high-affinity ligand recognition of adenosine diphosphates and triphosphates and selectivity identical to that of the wild-type receptor.
    Vöhringer C; Schäfer R; Reiser G
    Biochem Pharmacol; 2000 Apr; 59(7):791-800. PubMed ID: 10718337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.